Investing
433 Articles
The three major U.S. stock indexes opened lower this morning after a weekend of mixed news from Asia. China’s trade…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday.…
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date…
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short…
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…
Some wireless companies oppose the use of their networks as a means to make political contributions. (Reuters) Chinese inflation falls as…
GlobeImmune, Inc. is the latest biotech to file for an initial public offering. Financial terms were not disclosed but the…
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday.…
While the Dow Jones Industrial Average, S&P 500 and NASDAQ are down slightly today after weak data on the U.S. labor…
Celgene Corporation (NASDAQ: CELG) is supposed to be one of the more promising biotechs out there. After all it was…
The three major US stock indexes opened lower this morning as markets reacted to a rise in the yield of…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday.…
Our top personal finance-related articles today. Your wallet will thank you later.